United States · Series B startup
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Follow CREATE Medicines and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$195Mraised across 2 rounds since 2023, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
ARCH Venture PartnersLead
Hatteras Venture PartnersLead
Newpath ManagementLead
8VCReported by Hatteras Venture Partners and 1 other
Source recorded
From CREATE Medicines's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ARCH Venture PartnersLHatteras Venture PartnersL8VCAlexandria Venture InvestmentsNewpath ManagementLMissing a round, or an investor who was in one? Tell us.
CREATE Medicines's investors include ARCH Venture Partners, Hatteras Venture Partners, 8VC, Alexandria Venture Investments and Newpath Management. ARCH Venture Partners led its latest round.
CREATE Medicines has raised $195M across 2 rounds since 2023.
CREATE Medicines's most recent round was a Series B of $122M in May 2026, led by ARCH Venture Partners.
Its most recent round, $122M in May 2026, is also its largest on record.
CREATE Medicines's first round on record, in May 2023, was backed by 8VC, ARCH Venture Partners and Alexandria Venture Investments and 1 others.
CREATE Medicines's latest named round is a Series B, in May 2026.
CREATE Medicines is based in the United States.
ARCH Venture Partners led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
